Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions

Epidermal growth factor receptor (EGFR) exon 20 insertion mutations (Exon20ins) account for 4–12% of all EGFR mutations in non-small cell lung cancer (NSCLC) patients. Data on the differences in clinical characteristics between patients with Exon20ins and major mutations (M-mut) such as exon 19 dele...

Descripción completa

Detalles Bibliográficos
Autores principales: Morita, Chie, Yoshida, Tatsuya, Shirasawa, Masayuki, Masuda, Ken, Matsumoto, Yuji, Shinno, Yuki, Yagishita, Shigehiro, Okuma, Yusuke, Goto, Yasushi, Horinouchi, Hidehito, Yamamoto, Noboru, Motoi, Noriko, Yatabe, Yasushi, Ohe, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455549/
https://www.ncbi.nlm.nih.gov/pubmed/34548567
http://dx.doi.org/10.1038/s41598-021-98275-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455549/
https://www.ncbi.nlm.nih.gov/pubmed/34548567
http://dx.doi.org/10.1038/s41598-021-98275-3

Ejemplares similares